Lauren Diebold

Northwestern University — United States

Medicine · Health Sciences

14h-index2.4kcitations22works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(6), Acute Lymphoblastic Leukemia research(5), Mitochondrial Function and Pathology(3), Cancer, Hypoxia, and Metabolism(3), Down syndrome and intellectual disability research(3)

Publications22 total

Lactate-dependent transcriptional regulation controls mammalian eye morphogenesis
Nature Communications·2023· 30 citedOpen Access
Pulmonary Fibrosis and Antioxidants: Finding the Right Target
American Journal of Respiratory Cell and Molecular Biology·2023· 5 citedOpen Access
Mitochondrial respiration controls the Prox1-Vegfr3 feedback loop during lymphatic endothelial cell fate specification and maintenance
Science Advances·2021· 36 citedOpen Access
Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis
Nature Metabolism·2018· 203 cited
The effects of Phosphorous and Nitrogen concentrations on Algal density
Journal of Introductory Biology Investigations·2018
ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes
Nature Communications·2018· 69 citedOpen Access
The mitochondrial respiratory chain is essential for haematopoietic stem cell function
Nature Cell Biology·2017· 301 citedOpen Access
Mitochondrial ROS regulation of proliferating cells
Free Radical Biology and Medicine·2016· 382 cited
HSC Fate Is Tethered to Mitochondria
Cell stem cell·2016· 9 citedOpen Access
TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions
Molecular Cell·2015· 513 cited
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
The Journal of Cell Biology·2015· 1 cited
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
The Journal of Experimental Medicine·2015· 79 citedOpen Access
Targeting SOD1 reduces experimental non–small-cell lung cancer
Journal of Clinical Investigation·2013· 205 citedOpen Access
The Chromosome 21 Kinase DYRK1A Controls Cell Cycle Exit and Survival During Lymphoid Development and Is a Novel Therapeutic Target In Acute Lymphoblastic Leukemia
Blood·2013· 1 cited
AKT is a therapeutic target in myeloproliferative neoplasms
Leukemia·2013· 87 citedOpen Access
Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling
Blood·2013· 57 citedOpen Access
Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL/Post-Print Title: Integrative screening approach identifies regulators of polyploidization and targets for acute megakaryocytic leukemia
2012
Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
Cell·2012· 150 citedOpen Access
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome
Journal of Clinical Investigation·2012· 178 citedOpen Access
Development of a Mouse Model of DS Megakaryoblastic Leukemia and Identification of the Hsa21 Gene DYRK1A as a Prominent Contributor to DS-AMKL
Blood·2010
page 1 of 2Next →

Frequent Co-authors

John D. Crispino(10), Navdeep S. Chandel(9), Sébastien Malinge(8), Benjamin J. Thompson(4), Meghan Bliss‐Moreau(4), Timothy M. Chlon(4), Clarisse Thiollier(4), Samuel E. Weinberg(3), Peng Gao(3), Sandeep Gurbuxani(3), Benjamin Goldenson(3), Thomas Mercher(3), Thierry Besson(3), Bertrand Leblond(3), Laurent Désiré(3), Hyea Jin Gil(2), Gina Kirsammer(2), Qiang Wen(2), Serena J. Silver(2), Monica Schenone(2)